Medication info
Newstazet Al Tablet 10/5 mg

Newstazet Al Tablet 10/5 mg

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›5.2mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Samjin Pharmaceutical Co., Ltd.
Appearance
Pink, oblong, film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP*3], 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202004607 · Approved 2020.06.23 · Insurance code 647805040

Summary

Main use
For the treatment of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response to treatment. Primary hypercholesterolemia The dose range is 10/5mg to 10/20mg once daily. The recommended starting dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Samjin Pharmaceutical Co., Ltd.

Efficacy & effects

For the treatment of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • increased LDL-cholesterol
  • increased apo B protein
  • increased triglycerides
  • increased non-HDL cholesterol
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
View approved original text

This medication is used for primary hypercholesterolemia, particularly including both familial and non-familial cases, and is used as an adjunct to dietary therapy to lower total cholesterol, LDL-cholesterol, apo B protein, triglycerides, and non-HDL cholesterol levels, and to increase HDL-cholesterol. It is also administered as a lipid-lowering agent to patients with an increased risk of atherosclerotic vascular disease due to hypercholesterolemia, and is used together with dietary therapy to effectively control blood lipid levels. Before treatment, secondary causes such as diabetes and hypothyroidism should be identified and treated if necessary, and treatment efficacy should be monitored through regular lipid testing. This medication is used in cases where dietary therapy has proven insufficient, and may also be used in cases of acute coronary events, referencing lipid levels for treatment. Therefore, this medication is safely and effectively used for the treatment of dyslipidemia.

How to take

Adult dose

This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response to treatment. Primary hypercholesterolemia The dose range is 10/5mg to 10/20mg once daily. The recommended starting dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This medication may pose a risk of muscle side effects, so if symptoms such as muscle pain or weakness occur, the prescribing physician should be notified immediately. In particular, severe myopathy or rhabdomyolysis may occur, and if such symptoms are suspected, treatment should be discontinued. Patients with poor liver function or a history of liver disease should avoid using this medication. Patients with severely impaired kidney function should also avoid this medication, and careful monitoring is needed for patients with mildly impaired kidney function. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. This medication may interact with other drugs, so anyone currently taking other medications should inform their physician or pharmacist. Individuals who consume alcohol excessively or have liver issues should use this medication cautiously, and regular liver function testing may be required. Liver enzyme levels may increase during treatment with this medication, so liver function tests should be conducted regularly. Use in children and the elderly is not recommended or requires caution. There is no specific antidote for overdose, so immediate medical attention is necessary. When storing this medication, keep it out of reach of children and do not transfer it to another container.

Side effects

Acute renal failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, dyspepsia, ALT elevation, edema, myalgia, AST elevation, headache, acute pyelonephritis, dry mouth, liver enzyme elevation, abnormal liver function tests, increase in serum lactate dehydrogenase, pruritus, upper respiratory infection, increased blood sugar, elevated serum CPK, chest discomfort, dizziness, drowsiness, neurodegenerative disorders, orthostatic dizziness, migraine, diabetes, glucose load impairment, depression, bronchitis, rhinitis, cystitis, tinea of fingernails and toenails, soft tissue infection, fatty liver disease, hepatic impairment, hepatic toxicity, acute hepatitis, toxic hepatitis, increase in gamma-glutamyl transferase, increased blood cholesterol, increased serum alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, sweating, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cysts, eyelid drooping, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, vascular edema, hypersensitivity reactions, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myopathy, myositis, weakness, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, eosinophilia with systemic symptom drug reaction syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, sleep disturbances, insomnia, nightmares, interstitial lung disease, sexual dysfunction, gynecomastia, fatal liver failure, non-fatal liver failure, cognitive decline, forgetfulness, amnesia, memory impairment, confusion, severe muscle weakness, ocular muscle weakness, CK elevation, constipation, weakness, joint pain, fatigue, numbness, sensory abnormalities, chest discomfort, loss of appetite, abdominal distension, syncope, widespread pain, muscle cramps, gout, erectile dysfunction, chest pain, strange sensations, drug intolerance, colon polyps, irritable bowel syndrome, esophagitis, drowsiness, neurodegenerative disorders, orthostatic dizziness, migraine, diabetic neuropathy, tremors, upper abdominal pain, vomiting, gastritis, xerostomia, epigastric discomfort, belching, gastrointestinal disturbances, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, cough, sputum, runny nose, limb pain, diabetes, hypoglycemia, anemia, splenomegaly, urticaria, sweating, rash, itching, upper respiratory infection, conjunctival injection, renal failure, abnormal liver function, increased serum creatinine, elevated blood pressure, increased serum urea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It should be kept at room temperature, ideally between 1 degree and 30 degrees Celsius, avoiding extreme temperatures.

Appearance and packaging

Appearance

Pink, oblong, film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP*3], 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.